Gilead’s Top Lawyer Leaving After Big Stock Sale, Settlements

Deborah Telman, Gilead Sciences Inc.'s top lawyer for the past three years, is relinquishing her duties as general counsel and head of corporate affairs effective Dec. 5.

No reason was given Wednesday in the securities filing for Telman’s pending departure. It comes six months after the drug giant finalized a $202 million settlement with the US government over claims that it paid kickbacks to doctors as an inducement for prescribing the company’s HIV drugs. Gibson, Dunn & Crutcher LLP represented Gilead in that agreement, one of several HIV-related drug cases the biopharmaceutical company has sought to resolve in recent ...